Cartalax is a regulatory peptide complex associated with cartilage and connective-tissue motif research. Its sequence composition supports studies of chondrocyte signaling, extracellular-matrix synthesis, and redox balance in vitro. Researchers monitor structural integrity and receptor engagement under physiological conditions. Applications include tissue-regeneration modeling, peptide-therapy mechanistic work, and matrix-peptide interaction analysis.
CAT No: Z10-101-225
Synonyms/Alias:Ala-Glu-Asp; alanyl-glutamyl-aspartic acid; Cartalax; T-31 peptide; H-Ala-Glu-Asp-OH; SCHEMBL5324601; CHEBI:158137; GLXC-25918; L-Alanyl-L-glutamyl-L-aspartic acid; (2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-carboxybutanoyl]amino]butanedioic acid
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More